0001214659-19-007373.txt : 20191122 0001214659-19-007373.hdr.sgml : 20191122 20191122164608 ACCESSION NUMBER: 0001214659-19-007373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191120 FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER BRUCE L A CENTRAL INDEX KEY: 0001225503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 191242287 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-46374.xml PRIMARY DOCUMENT X0306 4 2019-11-20 0001576263 Mirati Therapeutics, Inc. MRTX 0001225503 CARTER BRUCE L A C/O MIRATI THERAPEUTICS, INC 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 true false false false Common Stock 2019-11-20 4 M false 3000 6.78 A 3000 D Common Stock 2019-11-20 4 S false 3000 94.74 D 0 D Non-Qualified Stock Option (right to buy) 6.78 2019-11-20 4 M false 3000 0 D 2026-09-26 Common Stock 3000 13000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant. /s/ Vickie Reed, Attorney-in-Fact 2019-11-22